Effects of some β-carboline alkaloids on intact Trypanosoma cruzi epimastigotes

Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology

Volumn 122, Issue 1, 1999, Pages 27-31

  Rivas, Pilar ^a   Cassels, Bruce K ^a   Morello, Antonio ^b   Repetto, Yolanda ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

carboline alkaloids; Harmaline; Harmane; Harmine; LQ strain; Parasiticidal drugs; Trypanosoma cruzi; Trypanosomicidal drugs; Trypanosomicidal effect; Tulahuen strain

Indexed keywords

ALKALOID; ANTITRYPANOSOMAL AGENT; BETA CARBOLINE DERIVATIVE; HARMALINE; HARMAN; HARMINE; NIFURTIMOX;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; EPIMASTIGOTE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY CHAIN; STRAIN DIFFERENCE; TRYPANOSOMA CRUZI;

ANIMALS; CARBOLINES; HARMALINE; HARMINE; KINETICS; NIFURTIMOX; OXYGEN CONSUMPTION; SPECIES SPECIFICITY; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 0032969774     PISSN: 07428413     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0742-8413(98)10069-5     Document Type: Article

References (27)

1. Agarwal A, Agarwal SK, Singh SM, Fatma N, Chatterjee RK In vivo potent antifilarial β-carbolines. Bioorg Med Chem Lett. 6:1996;225-228.
2. Aldunate J, Ferreira J, Letelier ME, Repetto Y, Morello A t-Butyl-4-hydroxyanisole, a novel respiratory chain inhibitor. Effects on Trypanosoma cruzi epimastigotes. FEBS Lett. 195:1986;295-297.
3. Aldunate J, Traipe L, Spencer P, Morello A, Repetto Y Effects of hydroquinones on intact Trypanosoma cruzi epimastigotes. Comp Biochem Physiol. 103C:1992;97-100.
4. Airaksinen M, Kari I β-Carbolines, psychoactive compounds in the mammalian body. Part I: Occurrence, origin and metabolism. Med Biol. 59:1981;21-34.
5. Beljansky M, Beljansky MS Selective inhibition of in vitro synthesis of cancer DNA by alkaloids of β-carbolines class. Exp Cell Biol. 50:1982;79-87.
6. Cavin J, Krassner S, Rodríguez E Plant-derived alkaloids active against Trypanosoma cruzi. J Ethnopharmacol. 19:1987;89-94.
7. Chiari E, Oliveira A, Raslan D, Mesquita A, Tavares K Screening in vitro of natural products against blood forms of Trypanosoma cruzi. Trans R Soc Med Hyg. 85:1991;372-374.
8. Codoñer A, Monzó I, Tomás F, Valero R Spectroscopic study of intermolecular complexes between FAD and some β-carboline derivatives. Spectrochim Acta. 42A:1986;765-769.
9. Codoñer A, Monzó I, Ortiz C, Olba A Spectroscopic study of molecular associations between riboflavin and some β-carboline derivatives. J Chem Soc Perkin Trans II. 1989:1989;107-111.
10. Docampo R, Stoppani AOM Generation of superoxide anion hydrogen peroxide induced by nifurtimox in Trypanosoma cruzi. Arch Biochem Biophys. 191:1979;317-321.
11. Fernández de Arriba A, Lizcano JM, Balsa MD, Unzeta M Inhibition of monoamino oxidase from bovine retina by β-carbolines. J Pharm Pharmacol. 46:1994;809-813.
12. Ferreira J, Coloma L, Fones E, Letelier ME, Repetto Y, Morello A, Aldunate J Effects of t-butyl-4-hydroxyanisole and other phenolic antioxidants on tumoral cells and Trypanosoma parasites. FEBS Lett. 234:1988;485-488.
13. Filardi LS, Brener Z Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' disease. Trans R Soc Trop Med Hyg. 81:1987;755-759.
14. Gustafsson LL, Beerman B, Abdi YA. Nifurtimox. In: Taylor, Francis, editors. Handbook of drugs for tropical parasitic infections. London: 83-85; 1987.
15. Hopp KH, Cunningham LV, Bromel MC, Schermeister LJ, Wahba Khalil SK In vitro antitrypanosomal activity of certain alkaloids against Trypanosoma lewisi. Lloydia. 39:1976;375-377.
16. Kondo K, Shigemori H, Kikuchi Y, Ishibashi M, Sasaki T, Kobayashi J Ircinals A and B from the okinawan marine sponge Ircinia sp.: Plausible biogenetic precursors of manzamine alkaloids. J Org Chem. 57:1992;2480-2483.
17. Letelier ME, Rodriguez E, Wallace A, Lorca M, Repetto Y, Morello A, Aldunate J Trypanosoma cruzi: A possible control of transfusion induced Chagas' disease by phenolic antioxidants. J Exp Parasitol. 71:1990;357-363.
18. Leteurtre F, Madalengoitia J, Orr A, Cuzi T, Lehnert E, Macdonald T, Pommier Y Rational design and molecular effects of a new topoisomerase II inhibitor, azatoxin. Cancer Res. 52:1992;4478-4483.
19. Maya JD, Repetto Y, Agosin M, Ojeda JM, Tellez R, Gaule C, Morello A Effects of nifurtimox and benznidazole upon glutathione and trypanothione in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi. Mol Biochem Parasitol. 86:1997;101-106.
20. Moncada C, Repetto Y, Aldunate J, Letelier ME, Morello A Role of glutathione in the susceptibility of Trypanosoma cruzi to drugs. Comp Biochem Physiol. 103C:1989;87-91.
21. Morello A, Aldunate J, Repetto Y. Present status of Chagas' disease chemotherapy at the molecular level. In: Ehrlich R, Nieto A, editors. Biology of parasitism. Trilce, Montevideo, 33-39;1994.
22. Repetto Y, Opazo E, Maya JD, Agosin M, Morello A Glutatione and trypanothione in several strains of Trypanosoma cruzi. Effect of drugs. Comp Biochem Physiol. 115B(2):1996;281-285.
23. Sepúlveda-Boza S, Cassels BK Plant metabolites active against Trypanosoma cruzi. Planta Med. 62:1996;98-105.
24. Torreilles J, Guérin MC, Previero A Des structures simples aux potentialités pharmacologiques élévées: les β-carbolines. Origines, synthèses, propriétés biologiques. Biochimie. 67:1985;929-947.
25. Tracy JW, Webster LT Jr. Drugs used in the chemotherapy of protozoal infection. In: Hardman JG, Limbird E, Molinoff PB, Ruddon RW, Goodman, A, Gilman, A, editors. The pharmacological basis of therapeutics. New York: McGraw-Hill, 987-1008;1996.
26. WHO Expert Committee. In: WHO Technical Report Series 811. Control of Chagas' Disease; Geneva, 1991; pp. 1-36.
27. Wright CW, Bray DH, O'Neill MJ, Warhurst DC, Phillipson JD, Quetin-Leclercq JL, Angenot L Antiamoebic and antiplasmodial activities of alkaloids isolated from Strychnos usambarensis. Planta Med. 57:1991;337-340.